Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis:a multicentre, randomised controlled trial (NeoPIns)

Autor: B Manai, M Stocker, Fam van den Dungen, Mathias Nelle, Matteo Fontana, Faba Schuerman, L de Ligt, M Visnovska, S Alliston, SD Sie, Mark Alan Fontana, Angelique Hoffman-Haringsma, S Hill, MM van Weissenbruch, René F. Kornelisse, Albertine E Donker, D Glauser, Wendy van Herk, R Kornelisse, N Lanz, Laura H van der Meer-Kappelle, Groot A van Rossum, Sintha D. Sie, R Moonen, S Dutta, EG Visser, M Strik, W van Herk, Rob Moonen, LJ Schlapbach, Salhab el Helou, Urs Zimmerman, Martin Stocker, A Donker, M Batstra, Jantien W Wieringa, Luregn J. Schlapbach, Peter Andriessen, GJ van der Geijn, Wim C. J. Hop, J van der Velden, AC de Mol, U Zimmerman, LH van der Meer-Kappelle, A van Rossum, David Pogorzelski, Sten P. Willemsen, S Siiskonen, Jan Janota, A Haringsma, Ipe Gondriet, Juliette van Gijsel, S el Helou, Y.B. de Rijke, S Willemsen, Sourabh Dutta, Esther de Vries, S Hoekstein, E.G.E. de Vries, Mac Broeren, M Hofhuis, Amerik C. de Mol, J van Gijsel, Eline G. Visser, J Bolt-Wieringa, V Grey, Frank A B A Schuerman, K Hauff, Maren Tomaske, Marc-André Roy, S Donker, A Bakry, Madan Roy, HK van den Tooren-de, S Kittanakom, J Janota, Daniel Stok, J Asch van Wijk, K Kalaniti, M Tomaske, Annemarie M. C. van Rossum, Rita K van den Tooren-de Groot

Publikováno v: Stocker, M, van Herk, W, el Helou, S, Dutta, S, Fontana, M S, Schuerman, F A B A, van den Tooren-de Groot, R K, Wieringa, J W, Janota, J, van der Meer-Kappelle, L H, Moonen, R, Sie, S D, de Vries, E, Donker, A E, Zimmerman, U, Schlapbach, L J, de Mol, A C, Hoffman-Haringsma, A, Roy, M, Tomaske, M, Kornelisse, R F, van Gijsel, J, Visser, E G, Willemsen, S P, van Rossum, A M C & NeoPInS Study Group 2017, ' Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis : a multicentre, randomised controlled trial (NeoPIns) ', The Lancet, vol. 390, no. 10097, pp. 871-881 . https://doi.org/10.1016/S0140-6736(17)31444-7
Lancet (UK), 390(10097), 871-881. Elsevier Ltd.
The Lancet, 390(10097), 871-881. Elsevier Limited

Background Up to 7% of term and late-preterm neonates in high-income countries receive antibiotics during the first 3 days of life because of suspected early-onset sepsis. The prevalence of culture-proven early-onset sepsis is 0·1% or less in high-i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2fcd49b436336d996370910b9ffacc0
https://research.vumc.nl/en/publications/c69a05d1-c20f-4c78-ae0e-2da2022b86ae

Oxazaphosphorines: Cyclophosphamide and ifosfamide [Biomonitoring Methods, 2003]

Autor: K. Hauff, R. Schierl

Publikováno v: The MAK-Collection for Occupational Health and Safety

Published in the series Analyses of Hazardous Substances in Biological Materials, Vol. 8 (2003) The article contains sections titled: General principles Equipment, chemicals and solutions Equipment Chemicals Solutions Calibration standards Specimen c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0e2561b92bf55b20e2f899e1fe48504c
https://doi.org/10.1002/3527600418.bi5018e0008

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.